Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
NCT05726396Phase 2Recruiting
- Sponsor
- University of Minnesota
- Start
- Sep 2025
- Primary completion
- Feb 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Restorative Microbiota Therapy in immune-related colitis (IRC), sponsored by University of Minnesota. Started Sep 2025; status: recruiting.
02
Drugs
Restorative Microbiota Therapy
03
Conditions
immune-related colitis (IRC)
Beyond the preview
Go deeper on NCT05726396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726396.